Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,166 across all filing types
Latest filing 2025-09-03 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of U.S. FDA approval for Lupin Limited's Abbreviated New Drug Application (ANDA) for Risperidone extended-release injectable suspension. It includes details about the product, the technology platform, and statements from company executives. There are no financial statements, regulatory certifications, or detailed financial data. The document is an announcement of a regulatory approval event, not a financial report or management discussion. It is not a report publication announcement since it does not mention the release or availability of a report. The content fits best under a general regulatory announcement category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-09-03 English
General Updates
Environmental & Social Information Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It announces an ESG rating assigned independently by Crisil ESG Ratings for fiscal year 2025. The document is short (1975 characters) and serves as an announcement of ESG rating information rather than a detailed ESG report. It does not contain substantive financial data or detailed ESG performance metrics, but rather a notification of the rating assigned. This fits the category of Environmental & Social Information (SR) as it relates to ESG ratings and disclosures.
2025-08-29 English
ESG Rating by Crisil ESG Ratings & Analytics Ltd.
Regulatory Filings
2025-08-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the company's participation in an upcoming analyst/institutional investor meeting. It references Regulation 30 of SEBI Listing Regulations, which pertains to disclosure obligations. The document does not contain any financial data, detailed presentations, or reports but merely announces the event and notes that any presentation will be consistent with previously available materials. The length is about 2000 characters, which is short and typical for an announcement rather than a full report. Therefore, this document is best classified as an Investor Presentation announcement or update. However, since it does not contain the presentation itself but only the notice of participation in the event, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure under SEBI rules, rather than the presentation (IP) itself or a report publication (RPA).
2025-08-27 English
Intimation about participating in the Analyst/Investors Meet.
Regulatory Filings
2025-08-27 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a detailed notice related to the Annual General Meeting (AGM) of multiple companies, including Lupin Limited, Mahamaya Steel Industries Limited, and HCL Infosystems Limited. It discusses the dispatch of the AGM notice, the availability of the Annual Report for the financial year 2024-25, and the procedures for remote e-voting and participation in the AGM via video conferencing. The document references compliance with SEBI regulations and the Companies Act, 2013, and includes information about the electronic dispatch of the Postal Ballot Notice and the Annual Report. The content is primarily about the notice and procedural information for the AGM and the availability of the Annual Report, rather than the Annual Report itself or the full financial statements. The document length is 15,000 characters, which is substantial, but the content is focused on the notice and voting instructions rather than the report's financial data. According to the "Menu vs Meal" rule, since this document announces the dispatch and availability of the Annual Report and the AGM notice, it should be classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself.
2025-08-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.